more today. Management obviously has the backing of existing investors. I believe share price is likely being constrained due to perception that these guys are about to do a massive public deal. Unlikely at this juncture. My bet remains incremental raises until they either ink a commercial transaction ( France?Spain?Middle East? Far East? )and/or go back to the well with some of the largest investors to round out the capital needs. Today's $$$$ assures that they have enough to manufacture and roll out marketing in Germany & Austria.
13MM market cap for an approved product with$500MM plus sales potential Ex- US. Expansion into oncology coming soon. Do the math. They either execute within the next year or this gets taken out by someone who can. Long and Hopeful.